Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point

In Depth

On Air

Archive
Feedback
Low Graphics
Help

Wednesday, September 29, 1999 Published at 18:09 GMT 19:09 UK


Health

Bacteria hope to beat asthma

Differences in types of DNA hold the key

Sniffing DNA from bacteria might help prevent asthma attacks and scientists are now looking to develop inhalers containing genetic material for sufferers.

The researchers, from the University of Iowa, reckon such a product might be available within five years - even though they have only so far tested their theory on mice.

They found that mice who sniffed DNA from bacteria were less likely to develop asthma and other allergies.

Another study - conducted in the UK - has also shown promise for a vaccine using bacteria found in soil.

Different reactions

The Iowa researchers think exposure to the genetic material caused the mice to develop what are know as Th1 immune responses as opposed to Th2 responses - and Th2 responses are thought to trigger allergies.


[ image: Bacteria have more CpG DNA]
Bacteria have more CpG DNA
The researchers believe the key ingredient is a type of DNA called CpG DNA, which is made up of substances called cytosine and guanine and is more plentiful in bacteria's genetic make-up than in humans'.

Dr Joel Kline, a lung specialist at the University of Iowa, led the research and believes early exposure to bacterial DNA pushes the body's immune system to favour a Th1 rsponse.

"It makes sense," he told the magazine. "Your body can't wait weeks for a specific antibody to be produced to begin attacking."

Immune response

Dr Kline's team used parasite eggs to sensitise the immune systems of 12 mice - when the animals were exposed to a protein from the eggs later on they developed many symptoms of asthma.

Some of the mice were then given eggs mixed with CpG DNA - when those mice next sniffed the protein their symptoms were far less severe than the others.

An inhaler strategy was then tested by placing a protein that causes allergies mixed with the DNA on the nostrils of the mice.

They also failed to develop asthma-like symptoms.

The research was presented at a workshop on bacterial DNA in Germany and was reported in New Scientist magazine.

Dirty solution

Scientists are also investigating the possibility of using DNA from bacteria in soil as a vaccine for asthma following early results from a British trial.

The drug, called SRL172, produced a 30% reduction in the narrowing of the patients' airways when they were exposed to the allergen, compared to their response before they received the drug.

However, it is not yet known if the effect lasts longer than the six weeks of the trial. Furthermore, the trial involved just 24 adult patients, a random half of whom received placebos.

Professor Stephen Holgate, at Southampton University where the trial was conducted, said that modern life was just too clean in developed countries.

"Infants need to get infections to develop the immune responses which protect them against allergies," he said.

"For example, Eastern European children have far lower rates of allergies than in the UK and have a completely different gut flora."

He added that ideally the asthma vaccine would be a DNA vaccine using genetic material taken from the soil bacteria: "This would be a purer substance."



Advanced options | Search tips




Back to top | BBC News Home | BBC Homepage | ©


Health Contents

Background Briefings
Medical notes

Relevant Stories

29 Sep 99 | Health
Asthma risk for big babies

11 Dec 98 | Medical notes
Asthma factfile

12 Mar 99 | Health
Study 'proves' asthma cause

26 Nov 98 | Health
Asthma vaccine trials start

01 Oct 98 | Health
Clones help you breathe more easily





Internet Links


University of Iowa

University of Southampton

National Asthma Campaign

New Scientist


The BBC is not responsible for the content of external internet sites.




In this section

Disability in depth

Spotlight: Bristol inquiry

Antibiotics: A fading wonder

Mental health: An overview

Alternative medicine: A growth industry

The meningitis files

Long-term care: A special report

Aids up close

From cradle to grave

NHS reforms: A guide

NHS Performance 1999

From Special Report
NHS in crisis: Special report

British Medical Association conference '99

Royal College of Nursing conference '99